Laser showdown: which technology smashes kidney stones best?
NCT ID NCT07516106
First seen Apr 07, 2026 · Last updated Jun 16, 2026 · Updated 15 times
Summary
This study compares two types of lasers used to break up kidney stones during a procedure called ureteroscopy. About 70 adults with a single stone or multiple stones totaling 7-20 mm will be randomly assigned to receive either a pulsed Thulium laser or a pulse-modulated Holmium laser. The main goal is to see which laser leaves fewer stone fragments behind and how efficient each is in terms of time and energy used.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY STONE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mayo Clinic Arizona
Phoenix, Arizona, 85054, United States
-
NYU Langone Health
New York, New York, 10016, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.